About
Technology
Issues
FAQ
Links
Official Page
One-year duration of nivolumab plus ipilimumab in patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC): Long-term follow-up of the GERCOR NIPICOL phase II study.
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.